Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Navelbine and the anthrapyrazoles

A L Jones1, I E Smith

  • 1Department of Clinical Oncology, Royal Free Hospital, London, England.

Hematology/Oncology Clinics of North America
|February 1, 1994
PubMed
Summary

This review covers navelbine and anthrapyrazole drug development, focusing on structural differences that may offer clinical benefits. Early preclinical and clinical trial data are examined for these promising anticancer agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Childhood Exposures to Fluorides and Cognitive Neurodevelopment: A Population-Based Longitudinal Study.

Journal of dental research·2024
Same author

Pre-frontal stimulation does not reliably increase reward responsiveness.

Cortex; a journal devoted to the study of the nervous system and behavior·2023
Same author

Avian Papilloma and Squamous Cell Carcinoma: a Histopathological, Immunohistochemical and Virological study.

Journal of comparative pathology·2020
Same author

An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.

BMC pulmonary medicine·2019
Same author

Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.

BMC pulmonary medicine·2018
Same author

Public health and the necessary limits of academic freedom?

Vaccine·2016

Area of Science:

  • Oncology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Navelbine and anthrapyrazoles represent novel therapeutic agents.
  • Structural modifications of parent compounds are explored for enhanced efficacy.

Purpose of the Study:

  • To review preclinical and early clinical development of navelbine and anthrapyrazoles.
  • To discuss structural differences conferring potential clinical advantages.
  • To summarize findings from Phase I trials and outline future research directions.

Main Methods:

  • Review of preclinical data.
  • Analysis of clinical pharmacology.
  • Examination of Phase I trial results.

Main Results:

  • Preclinical data suggest potential efficacy.
  • Phase I trials provide initial safety and pharmacokinetic insights.
  • Structural variations are linked to potential therapeutic benefits.

Conclusions:

  • Navelbine and anthrapyrazoles show promise in early-stage development.
  • Further investigation in Phase II trials and comparative studies is warranted.
  • Structural optimization is key to maximizing clinical advantages.

Related Experiment Videos